Scott Randal W. 4
4 · BridgeBio Pharma, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Scott Randal W.
Director
Transactions
- Sale
Common Stock
2023-12-01$30.00/sh−1,500$45,000→ 11,000 total(indirect: See Footnote) - Sale
Common Stock
2023-12-01$28.50/sh−1,000$28,500→ 12,500 total(indirect: See Footnote)
Holdings
- 5,000
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.
- [F2]By Thinking Bench Capital LLC.